Innovation Campus Berlin

NUVISAN ICB, located in Berlin, Germany, is a newly established dynamic contract research organization with approximately 400 employees, created from a complete research department acquired from Bayer. With decades of experience and top-tier expertise in early drug discovery, combined with the spirit of a mid-sized family business, it has created an outstanding innovation campus for early drug research. The organization’s functions and capabilities span the entire pharmaceutical R&D value chain, including compound profiling, life sciences, and therapeutic research. With years of experience in the field of drug discovery within the pharmaceutical industry, they have translated this expertise into development areas such as peptides, PROTACs, and RNA-targeting small molecules.